DSP-2342 is under clinical development by Sumitomo Pharma America and currently in Phase I for Unspecified Psychiatric Disorders.

ANI Pharmaceuticals, Inc. (ANIP) announced Thursday the launch of Prucalopride Tablets, which is the generic version of the reference ...

I write about business model strategy and execution across healthcare. The pharmaceutical industry has long anticipated the dreaded day that finally arrived last week. The Department of Health and ...

Drospirenone (Slynd, Slinda, Lyzbet) is a synthetic spironolactone analogue with anti-mineralocorticoid activity. It is formulated as film coated tablets and coated tablets, tablets for oral route of ...